首页> 外文期刊>Oncology Research >Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27
【24h】

Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27

机译:通过靶向P27,细胞周期蛋白依赖性激酶抑制剂3促进鼻咽癌中的癌细胞增殖和肿瘤内核

获取原文
获取原文并翻译 | 示例
       

摘要

Nasopharyngeal carcinoma (NPC) is a common malignancy of the head and neck that arises from the nasopharynx epithelium and is highly invasive. Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which plays a key role in regulating cell division. Abnormal expression of CDKN3 has been found in numerous types of cancer. In the current study, we explored the possible role of CDKN3 in cell proliferation, ability to invade, and radiosensitivity in NPC cells. We reported that CDKN3 was upregulated and p27 was downregulated in NPC tissues and is associated with a worse prognosis for patients. In addition, downregulation of CDKN3 and upregulation of p27 decreased cell proliferation, induced cell cycle arrest, increased apoptosis, decreased cell invasion, and enhanced radiosensitivity. Silencing of p27 significantly inhibited the effects of the knockdown of CDKN3. Moreover, downregulation of CDKN3 and upregulation of p27 inhibited the increase in tumor volume and weight in implanted tumors, decreased the phosphorylation of Akt, and increased the expression of cleaved caspase 3 in tumors. CDKN3 expression was also inversely correlated with p27 expression in NPC patients. Knockdown of CDKN3 increased p27 expression. Silencing of p27 markedly inhibited the effects of CDKN3 on cell proliferation, cell cycle progression, apoptosis, invasion, and radiosensitivity. These results demonstrate that upregulation of p27 is involved in the knockdown of CDKN3-induced decrease in cell proliferation, increase in cell cycle arrest and apoptosis, decrease in invasion, and increase in radiosensitivity. The results demonstrate that the CDKN3/p27 axis may be a novel target in the treatment of NPC.
机译:鼻咽癌(NPC)是从鼻咽上皮产生的头部和颈部的常见恶性肿瘤,并且具有高度侵入性。细胞周期蛋白依赖性激酶抑制剂3(CDKN3)属于双特异性蛋白磷酸酶系列,其在调节细胞分裂中起着关键作用。在许多类型的癌症中发现了CDKN3的异常表达。在目前的研究中,我们探讨了CDKN3在细胞增殖中的可能作用,在NPC细胞中侵蚀性和放射敏感性。我们报道称CDKN3被上调,P27在NPC组织中下调,与患者的更糟糕的预后有关。此外,CDKN3的下调和P27的上调降低细胞增殖,诱导细胞循环骤停,增加的细胞凋亡,降低细胞侵袭,增强的放射敏感性。 P27的沉默显着抑制了CDKN3敲低的影响。此外,CDKN3的下调和P27的上调抑制了植入肿瘤中肿瘤体积和重量的增加,降低了AKT的磷酸化,并增加了肿瘤肿瘤裂缝胱天蛋白酶3的表达。 CDKN3表达也与NPC患者中的P27表达相反。 CDKN3的敲低增加了P27表达。 P27的沉默显着抑制CDKN3对细胞增殖,细胞周期进展,凋亡,侵袭和放射敏感性的影响。这些结果表明,P27的上调涉及CDKN3诱导的细胞增殖降低,细胞循环骤停度和细胞凋亡的增加,侵袭性降低,放射敏感性增加。结果表明CDKN3 / P27轴可以是治疗NPC的新靶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号